
|Articles|January 17, 2022
Daily Medication Pearl: Besifloxacin (Besivance)
Author(s)Saro Arakelians, PharmD
Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.
Advertisement
Medication Pearl of the Day: Besivance (besifloxacin)
Indication: Besifloxacin ophthalmic suspension (Besivance) 0.6% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.
Insight:
- Dosing: Instill 1 drop in the affected eye(s) 3 times a day, 4 to 12 hours apart for 7 days.
- Dosage forms:Ophthalmic suspension besifloxacin 6 mg/mL.
- Adverse events: The most common adverse reaction reported in 2% of patients treated with Besivance was conjunctival redness.
- Mechanism of action: Besifloxacin is a fluoroquinolone antibacterial agent.
- Manufacturer: Bausch & Lomb Incorporated.
Sources:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
Updated 2025-2026 COVID-19 Vaccine Nearly Halved ED Visits, Hospitalizations in CDC-Funded Study
3
The Biosimilar Conversation Nobody Is Having at the Pharmacy Counter: Why Adoption Is Still Struggling and What We Can Do About It
4
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
5



















































































































